Dealmakers Newsletter Update - August 2009
Sponsored this month by:
BioNetwork 2009
Laguna Niguel, California, USA - October 5-7, 2009
BioNetwork offers you the opportunity to meet with VPs of Business Development, Licensing, and Alliance Management from top companies offering their insights
Visit the conference website for more details
 |
- Editor's corner
- In the news
- NEW! Scorecard
- NEW! Partnering roundup
- Best practice articles
-
Forthcoming events
- Latest business reports
- On the move - latest updates
|
Editor's corner
Summer is here but there appears to be no let-up in M&A and partnering announcements. This is good news for the industry, showing that good opportunities are still in strong demand.
July saw in excess of 170 new partnering and 30 M&A deals being announced. Our Scorecards keep you up to date with deals and alliances as they are announced.
NEW! Our industry round-up and in the news sections are updated daily online, providing you with the latest trends from the world's most respected publishers and deal news direct from biopharma companies as they are announced.
Our publishing arm has been busy introducing new and revised reports - here are just a few of the titles new to 2009 rush to buy before price rises in the fall:
Option & Evaluation Agreements in Pharma and Biotech
Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 2nd edition
Merger and Acquisition Agreements in Pharma, Biotech and Diagnostics, 2nd edition
Oncology Partnering Agreements in Pharma, Biotech and Diagnostics
Manufacturing and Supply Agreements in Pharma, Biotech and Diagnostics, 2nd edition
Practical Guide to Finding Partners in Pharma & Biotech, 2nd edition
All for now - enjoy the summer.
-- Steve Poile --
In the news
The following are just some of the deals involving bigpharma announced in the last few weeks:
Deals of note so far in August 2009:
- Forest to sell Nycomed's lung drug Daxas in USA
- GlaxoSmithKline and Vernalis sign up to cancer deal
- Opexa Therapeutics stem cell technology acquired by Novartis
- Nabi Biopharmaceuticals sells PentaStaph(tm) to GlaxoSmithKline
- NicOx reacquires rights to PF-03187207 for glaucoma from Pfizer
- Astellas to co-promote AstraZeneca asthma drug in Japan
- Zogenix and Astellas enter co-promotion agreement for Sumavel DosePro
Keep posted on the latest deals and alliances with CurrentPartnering's In the news feature
NEW! Partnering roundup
Just some of the articles picked up by Roundup during late July:
Follow Roundup online here
NEW: Scorecard
Our Scorecard Index provides a simple overview of recent partnering and M&A activity - see it now - Scorecard Index.
Updated monthly - we will be updating our Scorecard Index - tracking partnering and M&A deals announced every month.
In additon, we track the leading deals by value in the currect year, plus a compendium of top deals by value since 2000 - view details at Scorecard.
New and updated reports
New report titles:
CurrentPartnering has published new titles:
Oncology Partnering Agreements in Pharma, Biotech and Diagnostics
The Oncology Partnering Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the oncology partnering agreements entered into by the worlds leading biopharma companies
- Comprehensive directory of oncology deals since 2003
- Oncology contract documents
- Oncology agreement terms
- Oncology agreement structure
- Top oncology deals by value
- Most active oncology dealmakers
More details and order
Option & Evaluation Agreements in Pharma and Biotech
The Option and Evaluation Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the option and evaluation partnering agreements entered into by the worlds leading biopharma companies
More details and order
Royalty Financing Agreements in Pharma, Biotech and Diagnostics
The Royalty Financing Agreements in Pharma, Biotech and Diagnostics report provides detailed understanding and analysis of how and why companies enter royalty financing deals.
More details and order
Revised and updated reports:
CurrentPartnering has revised and updated its most popular reports:
Merger and Acquisition Agreements in Pharma, Biotech and Diagnostics, 2nd edition
The Merger and Acquisition Agreements in Pharma, Biotech and Diagnostics, 2nd edition report provides comprehensive understanding and unprecedented access to the merger and acquisition (M&A) agreements entered into by the worlds leading biopharma companies
More details and order
Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 2nd edition
The Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading healthcare companies. Revised and updated 2nd edition
More details and order
Practical Guide to Finding Partners in Pharma & Biotech, 2nd edition
CurrentPartnering’s Practical Guide to Finding Partners in Pharma & Biotech provides a comprehensive overview of all the steps required to identify and secure partnering either for an in-licensing or out-licensing activity
More details and order
New from Datamonitor:
Biotech Financing in the Credit Crisis: Strategies for a radically altered landscape
Since the financial meltdown, the relationship between Pharma and Biotech has been turned on its head. Previously, pharma companies had no choice but to license Biotech drugs at high prices in order to fill their sparse late stage pipelines
More details and order
Best practice articles
Mining Experiential Knowledge At Partnering Events - Part 2
The targeted information which is transferred in order to serve the intended partnering objective, is only one part of the informational interaction. The other part is an informational “by-product” which is not intended in the first place, and which is activated by communication, questions on the side, small talk - more
Mining Experiential Knowledge At Partnering Events - Part 1
When business development executives attend a euroPLX meeting (or any other partnering conference for that matter) they experience a learning process - more
Business speed dating at BIOTECHNICA 2009
Developing new business contacts is often time-consuming and costly. For this reason BIOTECHNICA now offers an affordable and speedy way for individuals and companies to link up with potential customers, suppliers and business partners - more
Protecting Intellectual Property Rights: Are Small Firms Handicapped?
This paper studies the determinants of patent suits and settlements during 1978-1999 by linking information from the U.S. patent office, the federal courts and industry sources. We find that litigation risk is much higher for patents owned by individuals and firms with small patent portfolios - more
Lost property: The European patent system and why it doesn’t work
In this paper, Bruno van Pottelsberghe focuses on the performance of the patent regime, the consistency of rules across countries and global governance questions concerning international cooperation among patent offices which are of major importance for competitiveness and growth - more
Read all our partnering best practice articles.
Forthcoming events
Here are some of our suggested events for fall 2009:
BioPharm America 2009
San Francisco, CA, USA - September 16-18, 2009 - more details
Pharmaceutical Strategic Alliances 2009
New York City, NY, USA - September 21-23, 2009 - more details
8th Annual Portfolio Evaluation and Strategic Investment Decision-Making
Philadelphia, PA, USA - September 22-23, 2009 - more details
EuroBio 2009
Lille, France - September 23-25, 2009 - more details
BioNetwork 2009
Laguna Niguel, California, USA - October 5-7, 2009 - more details
9th MedTech Investing Europe Conference
London, United Kingdom - October 5-6, 2009 - more details
Biotechnica 2009
Hannover, Germany - October 6-8, 2009 - more details
BioEurope 2009
Vienna, Austria - November 2-4, 2009 - more details
Therapeutic Area Partnerships 2009
Boston, MA, USA - November 17-19, 2009 - more details
View our full events calendar
People on the move
The following people have been reported on the move during July/August 2009:
Ruhi Kahn, John McCarthy, Roy Wu, Dave Iwanicki, Daniel Leone, John Sorvillo to name just a few
read more about the latest people on the move
If you have news about a business development executive who is on the move - let us know
Partnering resources
Current Partnering maintains and regularly updates this list of useful resources for dealmakers across all industries.
The following topic areas are available - updated regularly:
- Partnering organizations
- Financing organizations
- Online Partnering
- Weblogs
- Mentoring/Networking
- Checklists
- Quotes
- Software Tools
- Library
- Journals
- Careers
- Training/education
- Other useful links
Missing something? Let us know and we will include all appropriate resources.
Contact us
Steve Poile, Editor
Web: http://www.CurrentPartnering.com
Mail: CurrentPartnering, Allanmere House, 6 Hobgate, York, YO24 4HF, United Kingdom
Tel: +44 7896 656732
Fax: +44 8703 305993
Email
Advertizing and sponsorship
CurrentPartnering offers several advertising options, enabling your product or service to be promoted to our global business development audience - further details available online.
or contact us to discuss your requirements.
About CurrentPartnering
CurrentPartnering is an online provider of best practice, business information and intelligence for dealmakers
- Reports
- Articles
- In the news
- Networks
- Scorecard
- Events
- On the move
- Careers
- Glossary
- Resources
- Advisers
|